by Ubaka Ogbogu | Jan 4, 2011
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring...
by Stem Cell Network | Dec 29, 2010
Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new...
by Stem Cell Network | Dec 21, 2010
Ben Paylor introducing speakers at StemCellTalks by Ben Paylor, Maisam Makarem and Véronique Lecault December 3rd, 2010. 8:45am. The auditorium lights of the Michael Smith Laboratories at UBC dimmed on nearly 50 eager Greater Vancouver high school students and 15...
by Paul Krzyzanowski | Dec 20, 2010
Basic scientific research is a fundamental driver of improved quality of life that our society enjoys. However, it’s tacitly acknowledged that the benefits of research sometimes don’t materialize until some time has passed, with the finish line sometimes...
by Michelle Ly | Dec 20, 2010
Stem cells were high on the list of hot topics at this year’s American Society of Hematology conference in Orlando, Florida, particularly regarding the uses and effects of stem cells in the treatment of disease. The Ham-Wasserman lecture, named for two past ASH...
by Ubaka Ogbogu | Dec 16, 2010
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President...
by Ubaka Ogbogu | Dec 16, 2010
Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns...
by Paul Krzyzanowski | Dec 14, 2010
One of the biggest choices graduate students and post-doctoral fellow face is whether to stay in academia or go into the business world. But what if the two weren’t really that different? Traditional advice about running a successful academic research group...
by Chris Kamel | Dec 9, 2010
Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as...
by David Kent | Dec 7, 2010
My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in...
Comments